American Trust Sells 872 Shares of Danaher Co. (NYSE:DHR)

American Trust decreased its position in shares of Danaher Co. (NYSE:DHR) by 14.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,069 shares of the conglomerate’s stock after selling 872 shares during the quarter. American Trust’s holdings in Danaher were worth $1,409,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of DHR. Benjamin Edwards Inc. grew its stake in Danaher by 1.8% in the 2nd quarter. Benjamin Edwards Inc. now owns 2,153 shares of the conglomerate’s stock valued at $538,000 after buying an additional 38 shares during the last quarter. Wedge Capital Management L L P NC increased its stake in shares of Danaher by 3.2% during the third quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock worth $342,000 after purchasing an additional 38 shares during the period. Trust Co of Kansas lifted its holdings in Danaher by 4.1% during the 2nd quarter. Trust Co of Kansas now owns 1,022 shares of the conglomerate’s stock worth $255,000 after purchasing an additional 40 shares during the last quarter. Abacus Planning Group Inc. boosted its stake in Danaher by 0.7% in the 2nd quarter. Abacus Planning Group Inc. now owns 5,439 shares of the conglomerate’s stock valued at $1,359,000 after purchasing an additional 40 shares during the period. Finally, Certified Advisory Corp grew its holdings in Danaher by 4.5% in the 2nd quarter. Certified Advisory Corp now owns 926 shares of the conglomerate’s stock valued at $231,000 after buying an additional 40 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

DHR has been the subject of a number of recent research reports. Royal Bank of Canada reduced their target price on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. KeyCorp raised their target price on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Stephens reiterated an “overweight” rating and issued a $315.00 price target on shares of Danaher in a research note on Wednesday, October 23rd. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a report on Thursday, October 31st. Finally, TD Cowen increased their target price on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average target price of $287.16.

Danaher Trading Down 0.4 %

Shares of DHR stock opened at $234.50 on Friday. Danaher Co. has a twelve month low of $219.15 and a twelve month high of $281.70. The stock’s fifty day simple moving average is $247.62 and its 200 day simple moving average is $257.62. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $169.37 billion, a P/E ratio of 44.75, a P/E/G ratio of 4.33 and a beta of 0.83.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. During the same quarter last year, the business earned $2.02 EPS. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. As a group, sell-side analysts predict that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a $0.27 dividend. The ex-dividend date is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.46%. Danaher’s payout ratio is 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.